About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Prostate Cancer and Prostatic Diseases
›
Top Articles
Prostate Cancer and Prostatic Diseases
Urology
,
Oncology
6.2
(top 2%)
Impact Factor
6.7
(top 2%)
extended IF
72
(top 5%)
H-Index
1.3K
authors
1.7K
papers
32K
citations
3.2K
citing journals
19.3K
citing authors
Most Cited Articles of Prostate Cancer and Prostatic Diseases
Title
Year
Citations
Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer
2006
319
Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting
2010
224
Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia
1998
224
Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures
1999
209
ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
2010
204
Pathologic progression of autochthonous prostate cancer in the TRAMP model
1999
197
Increasing incidence of metastatic prostate cancer in the United States (2004-2013)
2016
158
Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999-2006
2011
156
Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation
2009
145
A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer
2013
137
Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes
2009
136
Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases
2013
134
Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve
2004
134
Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies
2013
126
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature
2012
125
The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo
2006
123
Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines
2006
122
Impact of diet on prostate cancer: a review
2005
121
Wnt signalling and prostate cancer
2005
121
Paucity of PD-L1 expression in prostate cancer: innate and adaptive immune resistance
2015
117
Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence
2010
116
miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression
2010
116
Microvessel density in prostate carcinoma
2002
115
A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo
2005
110
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations
2019
108
previous
2016
2017
2018
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.